Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01
Published December 17, 2014 · Recall initiated: December 5, 2014
Summary
FDA records drug Class III recall D-0291-2015, published December 17, 2014 and initiated December 5, 2014. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 1,008 bottles; Lot: Lot ET5122, Exp. 10/17. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sandoz Incorporated
- Distributor
- AZ
- Lot
- Lot ET5122, Exp. 10/17
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATriamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured byApril 25, 2018
- FDAAmitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-countJuly 12, 2017
- FDANadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJJanuary 4, 2017
- FDAGENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APPDecember 17, 2014
- FDATikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDCDecember 17, 2014
- FDAAlprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10August 6, 2014
Questions about this recall
Was Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01 recalled?
Yes. FDA published recall D-0291-2015 on December 17, 2014. Reported hazard: Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.
What should I do if I have this product?
Voluntary: Firm initiated · Letter